by Waylon Wright | Apr 1, 2019
Pearl Pathways will attend and exhibit at the upcoming Association of Clinical Research Professionals (ACRP) 2019 conference. The event takes place April 12 – 15 in Nashville, Tennessee. Stop by our booth (#549) to meet our team! About ACRP 2019 ACRP 2019 brings...
by Waylon Wright | Feb 5, 2019
Robert Seevers, Ph.D., Senior Advisor at Pearl Pathways, will discuss the right way to talk to FDA this Thursday, February 7, 2019 at a VisionTech Partners event. The event will take place from 5:30 – 7:30p PM EST at Leaf Software in Carmel, Indiana. Register...
by Waylon Wright | Nov 28, 2018
The current 510(k) regulatory review pathway for medical devices is poised for a significant overhaul, the U.S. Food and Drug Administration (FDA) announced this week. The proposal making the most headlines is that FDA aims to shift the industry towards medical...
by Waylon Wright | Nov 26, 2018
Pearl Pathways announces the hiring of Beckinam Nowatzke as a Quality Assurance and Regulatory Affairs (QA/RA) Advisor. Nowatzke brings over 17 years of experience across biotechnology, pharmaceutical, CRO, and medical device industries.An accomplished quality &...
by Waylon Wright | Nov 13, 2018
The United States Food and Drug Administration (FDA) set a new record for generic drug approvals in October 2018, RAPS reports. The new number to beat is 128. The 128-total comprised of 110 approvals and 18 tentative approvals, and also included 23 first generic drug...